Abstract
Background:
Identifying and treating chronic diseases, their precursors, and other cardiovascular disease (CVD) risk factors during family planning visits may improve long-term health and reproductive outcomes among low-income women. A cross-sectional study design was used to describe the prevalence of chronic diseases (hypertension, high cholesterol, and diabetes), their precursors (pre-hypertension, borderline high cholesterol, and pre-diabetes), and related CVD risk factors (such as obesity, smoking, and physical inactivity) among low-income women of reproductive age.
Methods:
Prevalence of chronic diseases, their precursors, and related CVD risk factors were assessed for 462 out of 859 (53.8%) female family planning patients, ages 18–44 years, who attended a Title X clinic in eastern North Carolina during 2011 and 2012 and consented to participate. Data were obtained from clinical measurements, blood test results, and questionnaire. Differences in distribution of demographic and health care characteristics and CVD risk factors by presence of prehypertension and pre-diabetes were assessed by Pearson chi-square tests.
Results:
The prevalence of hypertension was 12%, high cholesterol 16%, and diabetes 3%. Nearly two-thirds of women with hypertension were newly diagnosed (62%) as were 75% of women with diabetes. The prevalence of pre-hypertension was 35%, pre-diabetes 31%, obesity 41%, smoking 32%, and physical inactivity 42%. The majority of participants (87%) had one or more chronic disease or related cardiovascular disease risk factor.
Conclusions:
CVD screening during family planning visits can identify significant numbers of women at risk for poor pregnancy outcomes and future chronic disease and can provide prevention opportunities if effective interventions are available and acceptable to this population.
Introduction
Cardiovascular disease (CVD) is the leading cause of death among women overall and the third leading cause of death among women aged 18–44 years. 1,2 High blood pressure (BP), high cholesterol, and diabetes are simultaneously both CVD risk factors and chronic diseases that can manifest during women's reproductive years. For example, 10% of women ages 18–44 years have high BP and 3% have diabetes. 3 Additionally, 15% of women ages 20–45 years have high cholesterol. 4 Often, chronic diseases co-occur with other important CVD risk factors, including unhealthy weight and smoking. 5 Low-income women of reproductive age have higher rates of chronic disease and related CVD risk factors than higher income women. 6
Identification of chronic disease precursors (e.g., pre-hypertension, borderline high cholesterol, or pre-diabetes) and related CVD risk factors may be an important opportunity to prevent future chronic disease and improve the outcomes of future pregnancies. 7,8,9 For example, individuals with pre-hypertension are at high risk of developing hypertension in the future and atherogenesis is accelerated in individuals with borderline high cholesterol. 8,9 Similarly, individuals with pre-diabetes are at increased risk of developing diabetes within 5 years. 10 Early identification of these CVD risks is also important for women's health as the majority of cardiac sudden deaths in women occur in the absence of a previous diagnosis of heart disease. 11,12 Early identification of chronic diseases (e.g., hypertension or diabetes) is also important for preconception care and for preventing adverse pregnancy outcomes such as low birth weight, preterm deliveries, and birth defects. 13 Thus, taking advantage of opportunities to identify CVD risk factors and provide needed information and interventions to women of reproductive age could improve women's health and reproductive outcomes.
CVD risk factors that can adversely affect women's health and birth outcomes can be identified during routine reproductive healthcare visits. 14 Nearly 75% of women of reproductive age visit a health care provider annually for family planning services. 14 Title X (publicly funded) family planning clinics routinely screen women for hypertension, obesity, and smoking, but not for diabetes, high cholesterol, or other CVD risk factors. Because most women who seek health care services in Title X settings have no other source of preventive care, 15 Title X clinics offer an important opportunity to detect CVD risks in low-income women before pregnancy or before development of frank disease. 16,17
Knowledge about the prevalence of chronic diseases (hypertension, diabetes, and high cholesterol), their precursors (pre-hypertension, borderline high cholesterol, and pre-diabetes), and related CVD risk factors (such as obesity and smoking) among low-income women of reproductive age is incomplete. This study estimates the prevalence of these conditions and characteristics associated with pre-hypertension and pre-diabetes among low-income women of reproductive age in a Title X clinic in eastern North Carolina.
Materials and Methods
The Integrated Screening and Health Assessment, Prevention, and Evaluation (InShape) Study aimed to (1) develop and evaluate a screening program for CVD risk factors, (2) facilitate and monitor referrals for identified chronic diseases and related CVD risk factors, and (3) develop and test the effectiveness of two lifestyle counseling interventions that promoted a heart healthy diet (one also promoted increased physical activity, and the other promoted weight loss). InShape screening was conducted in a Title X family planning clinic, in Pitt County, eastern North Carolina. Pitt County is home to a large public university and affiliated academic medical center and has an estimated population 168,148. 18 This paper reports the baseline screening results for InShape.
A cross-sectional study design was used for the InShape screening study. All women were eligible to participate in the InShape screening study if they were 18–44 years old, non-pregnant, English speaking, and attending the family planning clinic at the local health department for an initial or annual reproductive health exam between May 23, 2011 and February 28, 2012. If interested in study participation, a research assistant met with them to answer questions, obtained written informed consent, and provided a self-administered 56-item questionnaire. The questionnaire required approximately 10 minutes to complete and included questions about background and medical history. As an incentive, participants were enrolled in a lottery with a 1/150 chance of receiving a $100 gift card. The Institutional Review Board of the University of North Carolina-Chapel Hill approved this study.
Family planning clinic staff routinely assessed BP, body mass index (BMI), and smoking, and documented findings in the medical charts. To facilitate clinic efficiency, the research team collaborated with clinic staff in planning the addition of screening for high cholesterol (total cholesterol [TC] and high-density-lipoprotein [HDL-C]) and diabetes (A1c) to routine services. A referral and follow-up protocol for elevated A1c was developed for the study. Referrals and follow up for high BP, high cholesterol, and obesity were provided in accordance with existing clinic protocols. (Although lipid screening is not part of routine care for all patients in the family planning clinic, the health department offered this screening to some high-risk patients, and thus already had a protocol for referral.) Limited data were abstracted from charts of patients who declined participation: visit type, age, race/ethnicity, preferred language, BMI, tobacco use, and BP.
Measurement of chronic disease, precursors, other CVD risk factors
In accordance with the health department protocol for usual clinical care, BP was assessed with a single nurse-administered measurement using automated equipment and recorded in patients' charts. Clinic lab technicians drew blood samples for hemoglobin A1c tests and sent them to a commercial laboratory (LabCorp). Initially, TC and HDL-C were assessed using a point-of-care test, at the request of clinic staff. However, a review of blood lipid results after 4 months of screening raised concerns that the point-of-care HDL-C levels were not valid, as many were lower than expected. Thus, parallel testing was performed (n=44), comparing point-of-care findings to a venous sample assessed by a commercial laboratory. This comparison confirmed systematically low HDL-C values from the point-of-care testing, and thereafter blood lipids were assessed by the commercial lab and lipid results are reported for this sub-sample (n=174). Additionally, participants responded to a self-administered questionnaire and self-reported current medication use for each chronic disease (hypertension, high cholesterol, and diabetes), tobacco use, physical activity, and family history of premature heart disease. BMI was obtained by clinical measurement and daily consumption of fruits and vegetables was obtained from chart review of self-reported clinical interview data.
Definitions
Study measures are defined in Table 1 and include chronic diseases (hypertension, diabetes, high cholesterol), chronic disease precursors (pre-hypertension, pre-diabetes, borderline high cholesterol), and other CVD risk factors (e.g., obesity, smoking, and physical inactivity). Measures of newly identified disease (yes/no) were also created for hypertension, diabetes, pre-diabetes, and high cholesterol based on self-reported history of no prior diagnosis and study measures.
Analytic plan
Descriptive statistics were used to estimate prevalence of demographic characteristics, health care access indicators, and CVD risk factors. Pearson chi-square, two-tailed tests (p<0.05) were used to assess differences in these distributions by presence of pre-hypertension or pre-diabetes. Potential confounders (age and race/ethnicity) were selected based on known associations from the literature, and multivariable Poisson regression with robust variance was used to evaluate whether significant associations remained after adjustment for confounders. Due to small numbers, distributions of demographic characteristics, health care access indicators, and CVD risk factors by hypertension, borderline or high cholesterol, and diabetes were not assessed. Analyses were conducted with Stata v.11 (StataCorp, 2007).
Results
Among 859 eligible patients, 68 (7.9%) were missed and not offered study participation, 329 (38.3%) declined, and 462 (53.8%) consented to participate. Patients who declined participation tended to be leaner (p=0.004) and have lower blood pressure than did enrolled women (p<0.0001, data not shown), but similar in age, race/ethnicity, and preferred language.
The median age of participants was 24.5 years (mean=26.4) with 74.9% being <30 years of age (Table 2). Approximately three-quarters were from racial/ethnic minority groups (63.0% Black, 8.2% Hispanic). While 61.9% of participants were not college educated, more than a third (38.3%) were students (high school or college). Most were uninsured or publicly insured (97.4%) and reported that the health department was their only source of preventive care or that they had no source of preventive care (93.1%). Nearly half of the sample (48.5%) had at least one previous live birth. Fewer than 15% indicated they had been tested for diabetes outside of pregnancy (14.7%) or that they had received a cholesterol test within the past 5 years (13.4%).
Due to missing data and rounding, values may not add to 462 or 100%, respectively.
Includes student, homemaker, other.
Includes Medicaid, US Government plans, Champus, and Veterans Affairs.
SD, standard deviation.
Prevalence of hypertension was 11.9%, pre-hypertension 35.1%, diabetes 2.6%, and pre-diabetes 31.0% (Table 3). Among the subsample with valid cholesterol data, 16.1% had high cholesterol. Additionally, 12.1% had borderline high cholesterol. Approximately one-third of all participants smoked (32.1%) and 87.2% of those were counseled to quit during their family planning visit. Prevalence of other CVD risk factors included obesity (40.7%), being physically inactive or insufficiently active (41.5%), and not consuming ≥5 fruits or vegetables daily (70.4%). Approximately 87% of women screened had one or more CVD risk factors. Nearly two-thirds of participants expressed interest in learning more about the lifestyle intervention (n=74, 16.2%), the weight loss intervention 59 (12.9%), or both interventions (n=156, 34.1%) offered as part of this study. The remainder of participants were unsure (n=56, 12.2%) or not interested in either (n=113, 24.7%). Interest in interventions did not differ by age, race/ethnicity, education, or insurance status. However, compared with participants who were unsure or not interested in either intervention, those who were interested in either/both interventions were statistically more likely to be obese (p<.001), inactive (p=.046), or to have pre-hypertension (p=.010), or pre-diabetes (p=.005).
Due to missing data and rounding, values may not add to 462 or 100%, respectively.
Includes women who are currently taking medication for high blood pressure.
Includes women who are currently taking medication for diabetes.
Based on commercial lab results (n=174).
Defined as total cholesterol (TC)<200 and high-density-lipoprotein cholesterol (HDL-C)≥40.
Defined as TC 200–239 and HDL-C≥40.
Defined as TC≥240 or HDL-C<40, or currently taking medication for high cholesterol, regardless of current TC or HDL-C levels.
Defined by self-reported average number of daily cigarettes smoked.
Inactive defined as no weekly physical activity (self-reported). Insufficiently active defined as some but <150 minutes of moderate- or <75 minutes of vigorous-effort activity per week, or an equivalent combination. Active defined as any combination totaling ≥150 minutes per week.
Identified through chart review of self-reported history.
Self-reported family history of early heart disease in a biological relative <65 years among mothers and sisters or <55 years among fathers and brothers.
Includes hypertension, high cholesterol, diabetes, any daily tobacco use, BMI≥30 kg/m2, physically inactive or insufficiently active, and <5 daily servings of fruit or vegetables.
SD, standard deviation; SBP, systolic blood pressure; DBP, diastolic blood pressure; HTN, hypertension; HDL-C, high density lipoprotein cholesterol; BMI, body mass index.
Many chronic diseases were newly identified (Fig. 1). Among those with hypertension, 34 of 55 (61.8%) were newly identified with the condition. Among those with diabetes, 9 of 12 (75.0%) were newly identified. Additionally, 138 of 143 (96.5%) participants with pre-diabetes were newly identified (not shown). Among women with high cholesterol, 23 of 28 (82.1%) were newly identified.

Percent of chronic diseases that were previously diagnosed and newly identified among female patients age 18–44 years screened at a family planning clinic in North Carolina 2011–2012 (n=462).
Table 4 displays associations between select characteristics with pre-hypertension and pre-diabetes. More than half of the women with pre-hypertension (55.6%) or pre-diabetes (52.5%) were obese or extremely obese. A higher percentage of women with pre-hypertension reported eating fewer than five daily servings of fruits or vegetables (78.6%), compared with those without pre-hypertension (66.0%) (p=0.006). Additionally, a higher percentage of pre-hypertensive women were physically inactive (47.8%) compared with normotensives (37.3%). However, after adjustment for age and race/ethnicity (Table 5), physical inactivity was not a statistically significant predictor of pre-hypertension. More women with pre-diabetes were non-Hispanic black (83.2%) than those with normal glucose (52.8%) (Table 4). Adjustment for age did not affect statistical significance (p<0.001, data not shown). A higher percentage of women with pre-diabetes were smokers (75.2%) compared with those without pre-diabetes (63.8%). However, the difference was not statistically significant after adjusting for age and race (Table 5). Statistically significant differences in insurance status were not observed for either precursor.
Pearson chi-square p<0.05.
n=407; excludes women previously diagnosed with hypertension outside of pregnancy or currently on medication for high blood pressure.
n=450; excludes women previously diagnosed with diabetes outside of pregnancy, or currently on medication for diabetes.
Defined as any self-reported daily cigarette smoking.
Defined as any combination of self-reported moderate or vigorous activity totaling <150 minutes per week.
Identified through chart review of self-reported history.
n=407; excludes women previously diagnosed with hypertension outside of pregnancy or currently on medication for high blood pressure.
n=450; excludes women previously diagnosed with diabetes outside of pregnancy, or currently on medication for diabetes.
Adjusted for age and race/ethnicity.
Defined as any self-reported daily cigarette smoking.
Defined as any combination of self-reported moderate or vigorous activity totaling <150 minutes per week.
Identified through chart review of self-reported history.
aPR, adjusted prevalence ratio; CI, confidence interval.
Discussion
Among low-income women accessing family planning services at this North Carolina Title X clinic, 4 out of 5 had at least one CVD risk factor. Of particular concern was the prevalence of pre-diabetes, pre-hypertension, smoking, and obesity; approximately 1 in 3 women had each of these conditions. Moreover, a large portion of chronic diseases and precursors were newly identified. The clinic was the only source of health care for almost all of the women in the study demonstrating the important prevention role that Title X clinics can have with uninsured, young women with CVD risk factors.
Only one published study was found that addressed chronic diseases in a Title X sample, but the researchers only reported prevalence among a select group of high-risk Title X patients. In that study, women at three Title X clinics in Baltimore, Maryland were offered screening for dyslipidemia and diabetes, based on CVD risk and age. 17 Of those who were screened for dyslipidemia (n=110), 84% had abnormal fasting lipid profiles and of those who underwent fasting blood sugars (n=61), 13% were abnormal. Prevalence estimates of dyslipidemia and diabetes among the present study's Title X sample were lower than those from the Baltimore study. 17 However, results from the present study were consistent with a previous study indicating high rates of chronic disease risk factors in low-income women of reproductive age. 6 Compared with other published estimates among women of reproductive age of all income levels, the present study found a higher prevalence of obesity (41% versus 17%–32%), 3,4,6,19 –21 smoking (32% versus 19%–26%), 3,4,6,19,20 and pre-diabetes (31% versus 8%). 22 While no published prevalence estimates were found for pre-hypertension or borderline high cholesterol among low-income women of reproductive age, supplemental analyses of National Health and Nutrition Examination Survey data (all income levels) indicate that national prevalence of pre-hypertension among women ages 18–29 years is 12.9% (95% CI 9.5–17.4) (unpublished analyses, 2007–2008). Clinic staff used the term “di-obesi-tension” to describe the major health problems affecting their patients and anticipated that the present study would confirm high prevalence of chronic diseases and related CVD risk factors in their clinic population. Although prevalence estimates of hypertension, diabetes, and high cholesterol were similar to estimates among women of reproductive age of all income levels, 3,4,19,20,23 the sample was young (median age 24.5 years) and had very high risk for multiple chronic diseases.
What the results most importantly indicate is that many women had precursors to chronic disease and CVD, precursors that could be reversed by losing weight, increasing exercise, and stopping smoking. Lifestyle interventions can prevent or delay onset of diabetes among pre-diabetics, 7,24 but these interventions have not been tested among women of reproductive age. Many women expressed interest in the offered interventions, particularly those with multiple CVD risk factors, but expressed interest does not necessarily translate into behavior change. Behavior changes are difficult, especially for women with limited resources, free time, and competing priorities. Reproductive age women have numerous demands on their daily lives that may affect their uptake of interventions. 25 Feasibility studies are needed to improve understanding about how to make these interventions appealing to and effective for young, low-income women.
This research contributes to the small literature that focuses on these conditions among low-income women of reproductive age. 6 The high prevalence of risk factors and chronic diseases identified in this low income, largely non-white cohort suggests subsidized family planning settings are important gateways for reaching women at high risk of underrecognized and undermanaged chronic diseases. Early identification and management of chronic diseases can impact women's health status throughout their lifespans. Reaching women of reproductive age in low-income family planning settings may also reduce the tremendous racial disparities in adverse pregnancy outcomes in the United States such as preterm birth, fetal growth restriction, fetal demise, and maternal mortality. 26 Another strength of this study is that the research design was developed in collaboration with clinic staff to minimize disruption of clinic flow and limit the number of patients requiring follow-up. Clinic staff involvement contributed to low rates of missing potential participants during recruitment, thus reducing selection bias. Point-of-care cholesterol testing was preferred by staff so that test results could be shared with patients while they were still at the clinic, eliminating the need for time-intensive follow-up. This clinic-centered approach to study design also was a limitation, as the point-of-care test results systematically underestimated HDL-C.
Due to invalid point-of-care cholesterol tests, the analyses of cholesterol status were limited by missing data on 62% of women. However, since cholesterol data is missing based only on date of visit, this likely only affects the precision of the estimate and should not bias the point estimate. Hypertension prevalence may be overestimated, as national guidelines require a diagnosis of hypertension to be based on two or more high BP measurements on two or more occasions after the patient has been sitting quietly for 5 minutes. This study assessed hypertension by a single measurement since research protocols were designed to minimize burden to staff time and disruptions to clinic flow. Additionally, white-coat hypertension could have led to inflated prevalence. Given the response rate of 54%, selection bias may have led to inflated prevalence estimates of chronic diseases, their precursors, and related risk factors as eligible women who declined enrollment tended to be leaner and normotensive. Some measures relied on self-report, which are subject to recall bias. Finally, generalizability may be limited due to the unique sample, which included a large percentage of students and a higher percentage of 18–24 year olds compared with the age distribution of Title X patients nationally. Also, this sample was limited to one Title X clinic which had fewer whites and Hispanic women compared with Title X as a whole, thus findings may not be generalizable to other Title X populations.
Conclusion
In summary, a high prevalence of pre-hypertension, pre-diabetes, obesity, and smoking was found in this sample of low-income women of reproductive age. Significant numbers of women at-risk for chronic disease and adverse pregnancy outcomes can be identified during family planning clinic visits, but research is needed to develop interventions that are appealing to this population and effective in addressing identified risk factors and chronic diseases.
Footnotes
Acknowledgments
The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention. This work was supported by Cooperative Agreement Number 5U48DP001944 from the Centers for Disease Control and Prevention. The authors gratefully acknowledge the Pitt County Health Department nurses and leadership for assisting in this study, particularly Deborah B. Herring, BSN, MHA, Stephanie Hart, RN, MA, and Susan S. Shelton, BSN. We also thank all of the women who participated in this project. The authors also express appreciation to Hubert W. Vesper, PhD, for his expert analysis of the cholesterol test results, Larry Johnston, MA; Anne Cole, BA; and Ziya Gizlice, PhD, for their roles in assuring data quality, and Merry-K Moos for her expert review of the manuscript.
Disclosure Statement
No competing financial interests exist.
